Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT (Journal of Clinical Immunology, (2019), 39, 7, (653-667), 10.1007/s10875-019-00659-8)

submitted on behalf of the Primary Immune Deficiency Treatment Consortium

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT (Journal of Clinical Immunology, (2019), 39, 7, (653-667), 10.1007/s10875-019-00659-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences